GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Clearbridge Health Ltd (SGX:1H3) » Definitions » ROE % Adjusted to Book Value

Clearbridge Health (SGX:1H3) ROE % Adjusted to Book Value : -244.57% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Clearbridge Health ROE % Adjusted to Book Value?

Clearbridge Health's ROE % for the quarter that ended in Dec. 2023 was -244.57%. Clearbridge Health's PB Ratio for the quarter that ended in Dec. 2023 was 1.00. Clearbridge Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -244.57%.


Clearbridge Health ROE % Adjusted to Book Value Historical Data

The historical data trend for Clearbridge Health's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearbridge Health ROE % Adjusted to Book Value Chart

Clearbridge Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.41 0.76 -28.36 -42.11 -122.64

Clearbridge Health Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.83 -33.39 -23.18 -18.55 -244.57

Competitive Comparison of Clearbridge Health's ROE % Adjusted to Book Value

For the Diagnostics & Research subindustry, Clearbridge Health's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clearbridge Health's ROE % Adjusted to Book Value Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Clearbridge Health's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Clearbridge Health's ROE % Adjusted to Book Value falls into.



Clearbridge Health ROE % Adjusted to Book Value Calculation

Clearbridge Health's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-122.64% / 1.00
=-122.64%

Clearbridge Health's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-244.57% / 1.00
=-244.57%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clearbridge Health ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Clearbridge Health's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Clearbridge Health Business Description

Traded in Other Exchanges
N/A
Address
37 Jalan Pemimpin, No. 08-05 Mapex, Singapore, SGP, 577177
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments of the company are Strategic investments; Healthcare systems; Medical clinics; Corporate segment and Investment. It derives key revenue from the Healthcare systems and Medical clinics. The Healthcare systems segment involves, provision of diagnostic services and manufacturing of and research and development on diagnostic related products, and provision of renal care services by partnering with medical device equipment manufacturers and hospitals. The Medical clinics segment involves, provision of general medical and clinical services. The group has a business presence in all over the world.

Clearbridge Health Headlines

No Headlines